OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada
Cayley Russell, Michelle Pang, Frishta Nafeh, et al.
International Journal of Qualitative Studies on Health and Well-Being (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

Patient Perspectives on Emergency Department–initiated Buprenorphine/Naloxone: A Qualitative Study
Qixin Liu, Katherin Badke, Serena S Small, et al.
The Canadian Journal of Addiction (2025) Vol. 16, Iss. 1, pp. 6-15
Closed Access | Times Cited: 1

The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review
Alison E. Adams, Sarin Blawatt, Tianna Magel, et al.
Substance Abuse Treatment Prevention and Policy (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 17

Feasibility and effectiveness of extended-release buprenorphine (XR-BUP) among correctional populations: a systematic review
Cayley Russell, Tony P. George, Nitin Chopra, et al.
The American Journal of Drug and Alcohol Abuse (2024) Vol. 50, Iss. 5, pp. 567-586
Open Access | Times Cited: 3

Characteristics, treatment patterns and retention with extended-release subcutaneous buprenorphine for opioid use disorder: A population-based cohort study in Ontario, Canada
Anita Iacono, Tianru Wang, Mina Tadrous, et al.
Drug and Alcohol Dependence (2023) Vol. 254, pp. 111032-111032
Open Access | Times Cited: 7

Opioid agonist treatment take-home doses (‘carries’): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA?
Cayley Russell, Shannon Lange, Fiona G. Kouyoumdjian, et al.
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 12

Cluster analysis to identify patient profiles and substance use patterns among pregnant persons with opioid use disorder
Elizabeth Charron, Ziji Yu, Brad Lundahl, et al.
Addictive Behaviors Reports (2023) Vol. 17, pp. 100484-100484
Open Access | Times Cited: 6

New Challenges and Opportunities for Opioid Agonist Treatment Access and Retention: A Scoping Review
Niamh Power, Léonie Archambault, Michel Perreault
Journal of Drug Issues (2024)
Closed Access | Times Cited: 1

The burden of drug overdose deaths among correctional populations: implications for interventions
Benedikt Fischer, Elnaz Moghimi, John R. Weekes
Canadian Medical Association Journal (2024) Vol. 196, Iss. 43, pp. E1414-E1416
Open Access

Factors associated with changes in illicit opioid use during the COVID-19 pandemic among incarcerated people who use drugs in Quebec, Canada
Hyejin Park, Blake Linthwaite, Camille Dussault, et al.
International Journal of Prisoner Health (2022) Vol. 19, Iss. 3, pp. 464-473
Open Access

Page 1

Scroll to top